Home / Inspections / 1229403

FDA Inspection 1229403 — Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. — FEI 3002936358

The FDA completed an inspection of Amphastar Pharmaceuticals, Inc. on March 1, 2024 in Rancho Cucamonga, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 1, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rancho Cucamonga, CA (United States)

Facility

Other inspections at this facility

  • 1266798 (NAI Thu Apr 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1144508 (NAI Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1113865 (NAI Fri Nov 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1115634 (NAI Thu Nov 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1100047 (NAI Thu Jul 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources